𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience

✍ Scribed by Magro, Fernando; Santos-Antunes, João; Vilas-Boas, Filipe; Rodrigues-Pinto, Eduardo; Coelho, Rosa; Ribeiro, Orquídea Silva; Lopes, Susana; Macedo, Guilherme

Book ID
122773317
Publisher
Oxford University Press
Year
2014
Tongue
English
Weight
695 KB
Volume
8
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vulval Crohn's disease: A tertiary cente
Vulval Crohn's disease: A tertiary center experience of 23 patients
✍ J. Landy; S.T.C. Peake; A. Akbar; A.L. Hart 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

s disease (CD) affecting the vulva is often unrecognized and can be difficult to treat. The majority of cases reported describe metastatic CD, where the vulval inflammation is not contiguous with the gastrointestinal tract. Overall, only 56 cases of vulval CD are reported in the literature since the

Predictors of adalimumab dose escalation
Predictors of adalimumab dose escalation in patients with crohn's disease at a tertiary referral center
✍ Russell D. Cohen; Jeffrey R. Lewis; Hannah Turner; Laura E. Harrell; Stephen B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg subcutaneously every 14 days, some patients require